149 related articles for article (PubMed ID: 9043027)
1. Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease.
Tampellini M; Berruti A; Gerbino A; Buniva T; Torta M; Gorzegno G; Faggiuolo R; Cannone R; Farris A; Destefanis M; Moro G; Deltetto F; Dogliotti L
Br J Cancer; 1997; 75(5):698-702. PubMed ID: 9043027
[TBL] [Abstract][Full Text] [Related]
2. Independent factors predict supranormal CA 15-3 serum levels in advanced breast cancer patients at first disease relapse.
Tampellini M; Berruti A; Gorzegno G; Bitossi R; Bottini A; Durando A; De Matteis A; Farris A; Donadio M; De Fabiani E; Manzin E; Arese P; Sarobba MG; Castiglione F; Moro G; Bonazzi G; Nuzzo F; Massobrio M; Dogliotti L
Tumour Biol; 2001; 22(6):367-73. PubMed ID: 11786730
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease.
Berruti A; Tampellini M; Torta M; Buniva T; Gorzegno G; Dogliotti L
Eur J Cancer; 1994; 30A(14):2082-4. PubMed ID: 7857707
[TBL] [Abstract][Full Text] [Related]
4. CA 15-3 value and neoplastic disease predictivity in the follow-up for breast cancer.
Busetto M; Vianello L; Franceschi R; Bolzan M
Tumour Biol; 1995; 16(4):243-53. PubMed ID: 7604205
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status].
Bensouda Y; André F; Boulet T; Al-Ghuzlan A; Conforti R; Troalen F; Bourgier C; Errihani H; Spielmann M; Delaloge S
Bull Cancer; 2009 Oct; 96(10):923-8. PubMed ID: 19696005
[TBL] [Abstract][Full Text] [Related]
6. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of CA 15-3 for detection of distant metastases in newly diagnosed breast cancer.
Gonssaud B; Goussot V; Berriolo-Riedinger A; Saïtta-Aribau E; Coutant C; Cochet A; Fumoleau P; Riedinger JM
Ann Biol Clin (Paris); 2017 Aug; 75(4):421-429. PubMed ID: 28751287
[TBL] [Abstract][Full Text] [Related]
8. Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysis.
Ebeling FC; Schmitt UM; Untch M; Nagel D; Fateh-Moghadam A; Stieber P; Seidel D
Anticancer Res; 1999; 19(4A):2545-50. PubMed ID: 10470192
[TBL] [Abstract][Full Text] [Related]
9. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of CA 15.3 kinetics for metastatic breast cancer.
De La Lande B; Hacene K; Floiras JL; Alatrakchi N; Pichon MF
Int J Biol Markers; 2002; 17(4):231-8. PubMed ID: 12521126
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of CEA for detection of distant metastases in newly diagnosed breast cancer: comparison with CA 15-3.
Maccio G; Goussot V; Berriolo-Riedinger A; Riedinger JM
Ann Biol Clin (Paris); 2017 Aug; 75(4):431-441. PubMed ID: 28751288
[TBL] [Abstract][Full Text] [Related]
12. Serum tumor marker CA 15.3 and stage are the two most powerful predictors of survival in primary breast cancer.
Kumpulainen EJ; Keskikuru RJ; Johansson RT
Breast Cancer Res Treat; 2002 Nov; 76(2):95-102. PubMed ID: 12452445
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers.
Lee JS; Park S; Park JM; Cho JH; Kim SI; Park BW
Breast Cancer Res Treat; 2013 Oct; 141(3):477-84. PubMed ID: 24072270
[TBL] [Abstract][Full Text] [Related]
14. Plasma TuM2-PK correlates with tumor size, CRP and CA 15-3 in metastatic breast carcinomas; short versus long term follow up study of the Egyptian breast cancer patients.
El-Abd E; El-Sheikh M; Zaky S; Fayed W; El-Zoghby S
Cancer Biomark; 2017 Aug; 20(2):123-133. PubMed ID: 28869444
[TBL] [Abstract][Full Text] [Related]
15. Comparison of bone scanning and CA 15-3 serum concentration in the follow-up of breast cancer.
Montravers F; Younsi N; Rousseau C; Philippe C; Seddiki M; Uzan S; Izrael V; Talbot JN
Anticancer Res; 1997; 17(3B):1683-6. PubMed ID: 9179218
[TBL] [Abstract][Full Text] [Related]
16. Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients.
Darlix A; Lamy PJ; Lopez-Crapez E; Braccini AL; Firmin N; Romieu G; Thezenas S; Jacot W
BMC Cancer; 2016 Jul; 16():428. PubMed ID: 27387327
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of preoperative CA 15-3 measurement in primary breast carcinoma.
O'Hanlon DM; Kerin MJ; Kent P; Maher D; Grimes H; Given HF
Br J Cancer; 1995 Jun; 71(6):1288-91. PubMed ID: 7779725
[TBL] [Abstract][Full Text] [Related]
18. Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer.
Shao Y; Sun X; He Y; Liu C; Liu H
PLoS One; 2015; 10(7):e0133830. PubMed ID: 26207909
[TBL] [Abstract][Full Text] [Related]
19. Comparison of bone scintigraphy with serum tumor markers of CA 15-3 and carcinoembryonic antigen in patients with breast carcinoma.
Gedik GK; Kiratli PO; Tascioglu B; Aras T
Saudi Med J; 2006 Mar; 27(3):317-22. PubMed ID: 16532090
[TBL] [Abstract][Full Text] [Related]
20. The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy.
Nicolini A; Ferrari P; Sagripanti A; Carpi A
Br J Cancer; 1999 Mar; 79(9-10):1443-7. PubMed ID: 10188888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
